B.O.S.S. Retirement Advisors, LLC Bristol Myers Squibb CO Transaction History

B.O.S.S. Retirement Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	BUY	$48.48 - $57.85 $200,804 - $239,614	4,142 New	4,142 $213 Million
Q4 2023 Jan 19, 2024	SELL	$48.48 - $57.85 $211,518 - $252,399	-4,363 Closed	0 $213 Million
Q4 2023 Jan 08, 2024	SELL	$48.48 - $57.85 $96 - $115	-2 Reduced 0.05%	4,363 $253 Million
Q3 2023 Oct 17, 2023	BUY	$57.89 - $64.73 $34,097 - $38,125	589 Added 15.6%	4,365 $253 Million
Q2 2023 Jul 10, 2023	SELL	$63.71 - $70.74 $1.16 Million - $1.28 Million	-18,142 Reduced 82.77%	3,776 $241 Million
Q1 2023 Apr 17, 2023	BUY	$65.71 - $74.53 $9,067 - $10,285	138 Added 0.63%	21,918 $1.52 Billion
Q4 2022 Feb 06, 2023	BUY	$68.48 - $81.09 $1.49 Million - $1.77 Million	21,780 New	21,780 $1.57 Billion

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of B.O.S.S. Retirement Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on B.O.S.S. Retirement Advisors, LLC with notifications on news.